Synexa Life Sciences is a diversified biotechnology company manufacturing high value, difficult-to-produce microbial secondary metabolites for pharmaceutical industries. Synexa uses a combination of traditional and proprietary cell culture technologies coupled with advanced automated purification systems in their production process.
Innate Immunotherapeutics is a medical biotechnology company designing and producing a unique immunomodulator microparticle technology. This innovative technology is able to induce the human immune system to fight certain types of cancer or infections, but also to modulate certain immune mechanisms implicated in autoimmune diseases (like the ones implicated in Multiple Sclerosis).
